Wuhan, China

JingJing Deng

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by JingJing Deng in Tumor Treatment

Introduction

JingJing Deng is an accomplished inventor based in Wuhan, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of tumor microparticles. His work focuses on enhancing the efficacy of chemotherapy and improving the tumor microenvironment.

Latest Patents

JingJing Deng holds a patent for a preparation method and application of tumor microparticles encapsulating metabolic inhibitors. This method involves cultivating tumor cells and adding a statin drug to the culture medium after the cells have grown stably. The tumor cells are then irradiated with ultraviolet light and incubated for 22 to 26 hours. Following this incubation, the cell supernatant is collected, and the tumor microparticles encapsulating the metabolic inhibitor are obtained through gradient centrifugation. This preparation method utilizes tumor cell-derived microparticles as drug delivery platforms, ensuring biosafety, biocompatibility, targeting, and intercellular communication. The discovery of new uses for statin drugs can inhibit tumor growth, regulate tumor metabolism, and enhance chemotherapy efficacy while delaying chemotherapy resistance.

Career Highlights

JingJing Deng is affiliated with Huazhong University of Science and Technology, where he continues to advance his research in cancer treatment. His innovative approach to utilizing tumor microparticles has the potential to revolutionize how tumors are treated and managed.

Collaborations

JingJing Deng collaborates with notable colleagues such as Yang Jin and WenJuan Chen, contributing to a dynamic research environment focused on cancer therapies.

Conclusion

JingJing Deng's innovative work in the preparation of tumor microparticles encapsulating metabolic inhibitors represents a significant advancement in cancer treatment. His contributions have the potential to improve patient outcomes and enhance the effectiveness of chemotherapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…